CN210170424U - Tic disorder therapeutic device placed in oral cavity - Google Patents
Tic disorder therapeutic device placed in oral cavity Download PDFInfo
- Publication number
- CN210170424U CN210170424U CN201920337701.2U CN201920337701U CN210170424U CN 210170424 U CN210170424 U CN 210170424U CN 201920337701 U CN201920337701 U CN 201920337701U CN 210170424 U CN210170424 U CN 210170424U
- Authority
- CN
- China
- Prior art keywords
- tongue
- oral cavity
- tic disorder
- contacts
- fixing parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000000214 mouth Anatomy 0.000 title claims abstract description 37
- 230000001225 therapeutic effect Effects 0.000 title claims abstract description 8
- 208000016686 tic disease Diseases 0.000 title claims description 23
- 238000011282 treatment Methods 0.000 claims description 24
- 238000004873 anchoring Methods 0.000 claims 2
- 230000000638 stimulation Effects 0.000 abstract description 17
- 210000004556 brain Anatomy 0.000 abstract description 14
- 210000003205 muscle Anatomy 0.000 abstract description 11
- 230000033001 locomotion Effects 0.000 abstract description 8
- 230000036461 convulsion Effects 0.000 abstract description 7
- 206010049816 Muscle tightness Diseases 0.000 abstract description 6
- 230000033228 biological regulation Effects 0.000 abstract description 4
- 230000001537 neural effect Effects 0.000 abstract description 4
- 206010028347 Muscle twitching Diseases 0.000 abstract description 3
- 230000008602 contraction Effects 0.000 abstract description 3
- 230000035807 sensation Effects 0.000 abstract description 3
- 210000002435 tendon Anatomy 0.000 abstract description 3
- 230000001052 transient effect Effects 0.000 abstract description 3
- 208000029578 Muscle disease Diseases 0.000 abstract description 2
- 210000004400 mucous membrane Anatomy 0.000 abstract description 2
- 230000003387 muscular Effects 0.000 abstract description 2
- 230000036961 partial effect Effects 0.000 abstract description 2
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 201000004311 Gilles de la Tourette syndrome Diseases 0.000 description 7
- 208000000323 Tourette Syndrome Diseases 0.000 description 7
- 208000016620 Tourette disease Diseases 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 238000013542 behavioral therapy Methods 0.000 description 5
- 238000012549 training Methods 0.000 description 5
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000001671 psychotherapy Methods 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 238000011491 transcranial magnetic stimulation Methods 0.000 description 4
- 239000000164 antipsychotic agent Substances 0.000 description 3
- 229940005529 antipsychotics Drugs 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 208000029726 Neurodevelopmental disease Diseases 0.000 description 2
- 230000001149 cognitive effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 230000002787 reinforcement Effects 0.000 description 2
- 210000002027 skeletal muscle Anatomy 0.000 description 2
- 210000002356 skeleton Anatomy 0.000 description 2
- BGRJTUBHPOOWDU-NSHDSACASA-N (S)-(-)-sulpiride Chemical compound CCN1CCC[C@H]1CNC(=O)C1=CC(S(N)(=O)=O)=CC=C1OC BGRJTUBHPOOWDU-NSHDSACASA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- CEUORZQYGODEFX-UHFFFAOYSA-N Aripirazole Chemical compound ClC1=CC=CC(N2CCN(CCCCOC=3C=C4NC(=O)CCC4=CC=3)CC2)=C1Cl CEUORZQYGODEFX-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000000561 anti-psychotic effect Effects 0.000 description 1
- 229940124604 anti-psychotic medication Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229960004372 aripiprazole Drugs 0.000 description 1
- 208000013404 behavioral symptom Diseases 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000001703 neuroimmune Effects 0.000 description 1
- 230000004007 neuromodulation Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000000955 prescription drug Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 230000003304 psychophysiological effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229960004940 sulpiride Drugs 0.000 description 1
- 230000003319 supportive effect Effects 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 208000027100 transient tic disease Diseases 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000001755 vocal effect Effects 0.000 description 1
Images
Abstract
The utility model relates to the field of medical equipment, a twitch obstacle therapeutic equipment placed in the oral cavity is provided. The connecting part is characterized by comprising two fixing parts which are sleeved on teeth and/or gums on two sides of an upper jaw or a lower jaw and have U-shaped sections, wherein one opposite sides of the two fixing parts are connected with connecting parts, the shape of each connecting part is matched with the shape of the inner wall of a partial oral cavity between the two fixing parts, and one side of each connecting part, which faces a tongue, is provided with a plurality of contacts. With these contacts, pressure sensation can be created on the tongue surface, and the resulting stimulation constantly adjusts the degree of muscular tension innervated by the brain when the mouth is quiescent; when the oral cavity moves, the intensity of a stimulation signal formed by the contact is increased, and the regulation of the brain on the muscle tension degree is increased; thereby reducing the occurrence of 'transient, rapid and repeated muscle twitch'; through the biting force of the upper jaw and the lower jaw and the movement muscles, muscle tendons and mucous membranes of oral bones, the brain center is excited, the output of neural information is actively fed back and adjusted, and the movement tension and the contraction frequency of the twitch disorder muscle group are adjusted.
Description
Technical Field
The utility model relates to the field of medical equipment, concretely relates to place in inside twitch obstacle therapentic equipment in oral cavity.
Background
Tic Disorder (TD) is the most common group of neurodevelopmental disorders that arise in childhood and adolescence. The clinical classification can be 3 types: transient tic disorder (also known as tic disorder), chronic motor or vocalization tic disorder, Tourette Syndrome (TS), i.e., vocalization and multiple motor combined tic disorder, with TS being the most typical. It is manifested as involuntary, repeated, and rapid motor and/or vocal jerks (including dry cough, throat clearing, and nasal sucking) of one or more muscles, accompanied by attention deficit, hyperactivity, compulsive movement or thinking, and other behavioral symptoms. The main expression is involuntary, purposeless, repeated and rapid contraction action; the pathogenesis is not clear. The incidence rate is 0.5-1/10 ten thousands, and the ratio of men to women is 3-5: 1. The disease has a long course of disease, generally more than 1 year, and can be as long as 10 years or more, and the disease has strong volatility, is obvious when the disease is hidden, but mostly disappears before and after puberty. The severity of the twitch was reduced in adults.
The disease brings great burden to families and society, brings great psychological burden to children and teenagers, and is not beneficial to the growth and success of children patients.
The etiology of this disease has not been elucidated, and recent studies suggest that this disorder may be the result of interactions with genetic factors, neurobiochemical factors, neuroimmune factors, stress, and environmental factors during childhood development.
There is currently a lack of effective therapeutic drugs and means.
Current treatments for this disease include antipsychotics such as sulpiride, aripiprazole, psychotherapy, behavioral therapy, and neuromodulation therapy. The use of antipsychotic medications ranges from a start dose, a treatment dose, a maintenance dose, to a decrement until discontinuation of the medication must be performed in compliance with the order. Non-drug treatment requires the cooperation and investment of guardians.
Nevertheless, the therapeutic effect on TD is limited. The prominent expression is as follows:
1. parents have many concerns about the child taking antipsychotics during the growth phase, including affecting normal growth and development and adverse effects caused by antipsychotics. And the antipsychotic drug as a prescription drug is often required to be attended to a psychiatry hospital with children, and the attendance at the psychiatry hospital allows children and people around the family to feel "shame" as children or themselves suffer from mental disease. Many children are therefore in a state without any treatment.
2. As one of the most common neurodevelopmental disorders, the existing non-drug effects are very limited.
The current non-drug treatment mainly comprises psychotherapy, behavior therapy and nerve regulation therapy, and comprises various psychotherapy methods such as education, habit reversal training, rhythm exercise training, positive reinforcement, relaxation training, negative exercise method, self-supervision method, cognitive behavior therapy and transcranial magnetic stimulation therapy.
2.1 psychological treatment
Including supportive psychotherapy, home intervention, and school intervention.
2.2 behavioral therapy
Various behavioral intervention approaches have been applied to the treatment of TD and have achieved good efficacy. Mainly including positive reinforcement, regression, intensive exercise, relaxation training, self-supervision, management methods based on function or situation, habit reversal training, exposure to effect prevention, cognitive behavior therapy.
2.3 neural modulation therapy
Nerve regulation and treatment methods such as electroencephalogram biofeedback, deep brain stimulation, transcranial magnetic stimulation and the like are increasingly concerned by many researchers at home and abroad, but the curative effect is still unknown. Moreover, deep brain stimulation is an invasive technique, the cost is high, the curative effect needs to be observed, and the deep brain stimulation is generally unacceptable for children and family members.
In summary, current treatments for TS are still lacking effective and acceptable treatment technologies.
At present, neural regulation and control treatment methods such as electroencephalogram biofeedback, deep brain stimulation, transcranial magnetic stimulation and the like are used for treating TS. The therapeutic efficacy of electroencephalogram biofeedback treatment TS is extremely limited and its efficacy has not been recognized by the international authorities applying the psychophysiological and biofeedback association (AAPB) and the international association for neurobiofeedback research (ISNR).
Deep brain stimulation is an invasive technique, the cost is high, the curative effect needs to be observed, and the deep brain stimulation is generally unacceptable for children patients and family members.
The stimulation part, stimulation frequency, stimulation intensity and stimulation treatment course of the transcranial magnetic stimulation treatment TS are not clear, the patient needs to come from a medical institution for treatment, and the key points are that the patient also has adverse reactions such as loud noise, headache, dizziness and the like, and the patient is clinically unacceptable to the patient and family members.
SUMMERY OF THE UTILITY MODEL
To solve the above technical problem or at least partially solve the above technical problem, the present application provides a tic disorder curer placed inside an oral cavity.
The utility model provides a pair of place in inside twitch obstacle therapentic equipment in oral cavity, establish the fixed part that two sections on palace or chin both sides tooth and/or gum are the U-shaped including the cover be connected with connecting portion between the opposite one side of fixed part, the shape and two of connecting portion the shape of partial oral cavity inner wall between the fixed part suits, connecting portion and two be equipped with a plurality of contacts on at least one in the fixed part.
Optionally, a plurality of contacts are arranged on one side of the connecting part facing the tongue.
Optionally, a plurality of contacts are arranged on one side of the connecting part back to the tongue
Optionally, a plurality of contacts are arranged on the outer wall of one side of at least one of the fixing parts, which faces away from the tongue.
Optionally, the connecting portion is connected to the U-shaped edges of the two fixing portions, and at least one of the fixing portions is provided with a plurality of contacts on a side facing the tongue.
Optionally, at least part of the fixing portion is sleeved on the gum, and a plurality of contacts are arranged on the inner wall of the fixing portion corresponding to the gum.
Optionally, the contact is a bump.
Optionally, at least one of the fixing parts is provided with a contact piece extending towards the U-shaped bottom of the fixing part, and a plurality of contacts are arranged on one side of the contact piece facing away from the tongue and/or one side facing the tongue.
Optionally, the length of the extended portion of the contact piece is greater than the height of the fixing portion.
Optionally, the contact piece has elasticity.
The tongue and/or the oral cavity can be pressed by using a plurality of contact points arranged on at least one of the connecting part and the two fixing parts, when the oral cavity is static, the contact points can actively form touch and pressure tension on the tongue and/or oral cavity muscles, and the tension can be used as stimulation to continuously adjust the muscle tension degree of brain domination; when the oral cavity is active or moving, the intensity of stimulation signals of touch sense and pressure sense generated by the bulges is increased, so that the adjustment of the muscle tension degree by the brain is increased; the brain adjusts the muscle tension degree to reduce the occurrence of 'transient, rapid and repeated muscle twitching', in particular the activities of expression muscles and skeletal muscles of the head and the face; through the biting force of upper and lower jaws, the oral skeleton movement excites muscles, tendons and mucous membranes to excite the brain center, the output of neural information is actively fed back and adjusted, the oral movement tension is adjusted, and the movement tension and the contraction frequency of the twitch disorder muscle group are adjusted.
Drawings
Fig. 1 is a schematic view of a perspective of a tic disorder treatment apparatus according to an embodiment of the present invention, placed inside the oral cavity;
fig. 2 is a schematic view of another perspective of the tic disorder treatment apparatus according to the embodiment of the present invention, placed inside the oral cavity.
Reference numerals:
1. a fixed part; 2. a connecting portion; 3. a contact piece.
Detailed Description
In order to make the above objects, features and advantages of the present invention more clearly understood, the present invention will be further described in detail with reference to the accompanying drawings and examples. It is to be understood that the embodiments described are some, but not all embodiments of the invention. The specific embodiments described herein are merely illustrative of the invention and are not intended to be limiting. All other embodiments, which can be derived from the description of the embodiments of the present invention by a person skilled in the art, are within the scope of the present invention.
With reference to fig. 1 and 2, a tic disorder therapeutic apparatus placed in an oral cavity according to an embodiment of the present invention includes two fixing portions 1 having U-shaped cross-sections and disposed on teeth and/or gums on two sides of an upper jaw or a lower jaw, a connecting portion 2 is connected between opposite sides of the two fixing portions 1, and the connecting portion 2 is adapted to a shape of a portion of an inner wall of the oral cavity between the two fixing portions 1, wherein, for a child whose teeth are not grown or are in a tooth picking stage, a portion of the fixing portions 1 may be disposed on the teeth, and another portion of the fixing portions 1 may be disposed on the gums; for the situation that the fixing part 1 is sleeved on the teeth and/or the gum of the upper jaw, the connecting part 2 is positioned above the tongue, and for the situation that the fixing part 1 is sleeved on the teeth and/or the gum of the lower jaw, the connecting part 2 is positioned below the tongue; the fixing parts 1 form a certain connecting force with teeth and/or gums in a sleeving manner, the connecting part 2 is used for fixing the relative positions of the two fixing parts 1, and the connecting part can be attached to the inner wall of the upper jaw or the lower jaw due to the shape of the connecting part being adaptive to the inner wall of the oral cavity, and the connecting part forms a certain connecting force with the upper jaw or the lower jaw by utilizing the atmospheric pressure, so that the whole therapeutic device is stably fixed on the upper teeth or the lower teeth.
Wherein, at least one of the connecting part 2 and the two fixing parts 1 is provided with a plurality of contacts, the contacts can be convex points which are convex outwards, concave pits which are concave inwards, and other shapes can be adopted, as long as the contact with the tongue of a person can generate the tactile sensation different from the contact with a smooth surface. The function of the contacts is to create pressure sensations on the inner walls of the mouth and/or on the upper or lower surface of the tongue, which when the mouth is at rest, create tactile and pressure-sensation tensions "actively" on the muscles of the mouth and/or tongue, these tensions acting as stimuli to constantly regulate the degree of muscular tension innervated by the brain; when the oral cavity is active or moving, the intensity of the stimulation signals generated by the bulges is increased, so that the adjustment of the muscle tension degree by the brain is increased; the brain adjusts the muscle tension degree to reduce the occurrence of 'transient, rapid and repeated muscle twitching', in particular the activities of expression muscles and skeletal muscles of the head and the face; through the biting force of upper and lower jaws, the brain center is excited through the movement of oral skeleton, muscle, tendon and mucosa, the output of nerve information is actively fed back and adjusted, and the mouth movement tension is adjusted.
In some embodiments, the side of the connecting portion facing the tongue is provided with a plurality of contact points, and the contact points stimulate the upper surface or the lower surface of the tongue, so that tactile and pressure stimulation is generated on the muscles of the tongue.
In some embodiments, the side of the connecting portion facing away from the tongue is provided with a number of contacts for stimulating the walls of the oral cavity above or below the tongue.
In some embodiments, the outer wall of the side of the at least one retainer part 1 facing away from the tongue is provided with a number of contact points for stimulating the walls of the mouth outside the teeth, thereby stimulating more muscle groups in the mouth.
In some embodiments, the connecting part 2 is connected to the U-shaped edges of the two fixing parts 1, so that the connecting part 2 and the fixing parts 1 are in smooth transition, discomfort is not caused to the oral cavity modeling, and the connecting part 2 can be exposed towards one side wall of the tongue; in addition, a plurality of contact points are arranged on one side of the at least one fixing part 1 facing the tongue, so that pressure tension is formed on the side part of the tongue.
In some embodiments, at least a portion of the fixing portion 1 is disposed on the gum, and a plurality of contacts are disposed on a portion of the inner wall of the fixing portion 1 corresponding to the gum, so as to stimulate the portion of the gum.
Since the fixing portion 1 is fitted to the teeth or the gums, the outer contour of the fixing portion 1 substantially matches the contour of the teeth or gums, and therefore, if only a few contact points are provided on the side of the fixing portion 1 facing away from the tongue, these contact points do not form a large range of stimulation with the oral cavity wall with a large intensity. Therefore, in the embodiment, the contact piece 3 extending towards the bottom of the U shape of the fixing part is arranged at the edge of one side of the at least one fixing part 1 facing away from the tongue, and the contact pieces 3 with the contacts are arranged at the side facing towards and/or facing away from the tongue, so that the contact piece 3 with the contacts can form a larger area and stronger contact with the inner wall of the oral cavity.
Further, the contact piece 3 extends out to a length greater than the height of the fixing portion 1, so that when the oral cavity is closed, the contact point on the contact piece 3 can be brought into contact with not only the oral cavity wall corresponding to the lower teeth but also the oral cavity wall corresponding to the upper teeth.
The contact piece 3 is preferably elastic so that it can be brought into contact with the oral cavity wall with a greater force by the elastic force and does not cause discomfort to the oral cavity.
Finally, it should be noted that: the above embodiments are only used to illustrate the technical solution of the present invention, and not to limit it; although the present invention has been described in detail with reference to the foregoing embodiments, it should be understood by those skilled in the art that: the technical solutions described in the foregoing embodiments may still be modified, or some technical features may be equivalently replaced; such modifications and substitutions do not depart from the spirit and scope of the present invention in its corresponding aspects.
Claims (10)
1. The tic disorder therapeutic device is characterized by comprising two fixing parts with U-shaped sections, wherein the two fixing parts are sleeved on teeth and/or gums on two sides of an upper jaw or a lower jaw, a connecting part is connected between one opposite sides of the two fixing parts, the shape of the connecting part is matched with the shape of the inner wall of a part of oral cavity between the two fixing parts, and at least one of the connecting part and the two fixing parts is provided with a plurality of contacts.
2. A tic disorder treatment device according to claim 1, wherein said connecting portion has a plurality of contact points on a side thereof facing the tongue.
3. A tic disorder treatment device according to claim 1, wherein the side of said connecting portion facing away from the tongue is provided with a plurality of contacts.
4. A tic disorder treatment device according to claim 1, wherein said at least one anchoring portion comprises a plurality of contacts on the outer wall of the side of said anchoring portion facing away from the tongue.
5. A tic disorder treatment device according to claim 1, wherein said connecting portion is connected to the U-shaped edges of two of said fastening portions, at least one of said fastening portions having a plurality of contact points on the side facing the tongue.
6. A tic disorder treating device according to claim 1, wherein at least a portion of said fixing portion is disposed on the gum, and a plurality of contacts are disposed on a portion of the inner wall of said fixing portion corresponding to the gum.
7. A tic disorder treatment device for placement within the oral cavity according to claim 1, wherein said contact is a bump.
8. A device as claimed in any one of claims 1 to 7, wherein at least one edge of the tongue facing away from the tongue is provided with a contact extending towards the base of the U-shape of the retainer, and the contact is provided with a plurality of contacts on the tongue facing side and/or the tongue facing side.
9. A tic disorder treatment device according to claim 8, wherein said contact piece extends a length greater than the height of said fixed portion.
10. A tic disorder treatment device according to claim 8, wherein said contact is resilient.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201920337701.2U CN210170424U (en) | 2019-03-15 | 2019-03-15 | Tic disorder therapeutic device placed in oral cavity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201920337701.2U CN210170424U (en) | 2019-03-15 | 2019-03-15 | Tic disorder therapeutic device placed in oral cavity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN210170424U true CN210170424U (en) | 2020-03-24 |
Family
ID=69829734
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201920337701.2U Active CN210170424U (en) | 2019-03-15 | 2019-03-15 | Tic disorder therapeutic device placed in oral cavity |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN210170424U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109938987A (en) * | 2019-03-15 | 2019-06-28 | 首都医科大学宣武医院 | It is placed in the tic disorder therapeutic equipment of cavity interior |
-
2019
- 2019-03-15 CN CN201920337701.2U patent/CN210170424U/en active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109938987A (en) * | 2019-03-15 | 2019-06-28 | 首都医科大学宣武医院 | It is placed in the tic disorder therapeutic equipment of cavity interior |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mannheimer et al. | Acute and chronic postural abnormalities as related to craniofacial pain and temporomandibular disorders | |
| Chen et al. | The Cambridge Neurological Inventory: a clinical instrument for assessment of soft neurological signs in psychiatric patients | |
| Glaros et al. | Bruxism: a critical review. | |
| US20030018247A1 (en) | Process for testing and treating aberrant sensory afferents and motors efferents | |
| Lance | Sporadic and familial varieties of tonic seizures | |
| Dieter et al. | Supplemental stimulation of premature infats: a treatment model | |
| US20180154149A1 (en) | Electric stimulator | |
| LANGWORTHY et al. | Syndrome of pseudobulbar palsy: an anatomic and physiologic analysis | |
| RU2518130C2 (en) | Method for recovering motion and psychoverbal functions in infantile cerebral paralysis | |
| CN210170424U (en) | Tic disorder therapeutic device placed in oral cavity | |
| CN210170425U (en) | Tic disorder therapeutic device placed in oral cavity | |
| AU2020102546A4 (en) | Interactive gaming device for cerebral palsy intervention, treatment and management and its method thereof | |
| Singh | The effects of facial screening on infant self-injury | |
| CN116850452A (en) | Sleep therapeutic apparatus and sleep therapeutic method for transcranial electrical stimulation during sleep monitoring | |
| Sixou et al. | Orofacial therapy in infants with Down syndrome | |
| Kerr et al. | Towards a full life with Rett disorder | |
| Luthe | About the methods of autogenic therapy | |
| Uswatte et al. | You can teach an old dog new tricks: harnessing neuroplasticity after brain injury in older adults | |
| Pearcey et al. | What lies beneath the brain: Neural circuits involved in human locomotion | |
| CN106344188A (en) | Occlusal pad manufactured based on occlusion theory | |
| CN109938987A (en) | It is placed in the tic disorder therapeutic equipment of cavity interior | |
| CN109938988A (en) | It is placed in the tic disorder therapeutic equipment of cavity interior | |
| Singh et al. | Effectiveness of Multi Sensory Stimulation Program with Median Nerve Stimulation in Post Head Injury Subjects with Decreased Level of Consciousness | |
| Holroyd et al. | Self-management of recurrent headache | |
| RU2773363C2 (en) | Intraoral training device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20230919 Address after: 4009, 4th Floor, Building 1, No. 35 West Fourth Ring South Road, Fengtai District, Beijing, 100071 Patentee after: Beijing Xuanyi Ruida Health Technology Co.,Ltd. Address before: No. 45 Changchun Street, Xicheng District, Beijing 100053 Patentee before: XUANWU HOSPITAL OF CAPITAL MEDICAL University |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20240312 Address after: 037301 Huilin Building, Yunzhou District, Datong City, Shanxi Province Patentee after: Xuanyi Ruida (Datong) Health Technology Co.,Ltd. Country or region after: China Address before: 4009, 4th Floor, Building 1, No. 35 West Fourth Ring South Road, Fengtai District, Beijing, 100071 Patentee before: Beijing Xuanyi Ruida Health Technology Co.,Ltd. Country or region before: China |
|
| TR01 | Transfer of patent right |